{"nct_id":"NCT06015737","title":"A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-06-29","start_date_type":"ACTUAL","primary_completion_date":"2027-12-29","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}